Clinical

Dataset Information

0

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)


ABSTRACT: This is an open-label, dose-escalation, phase I trial of the safety and efficacy of anti-CEA intraperitoneal CAR-T infusions for treatment in patients with CEA-expressing adenocarcinoma peritoneal metastases or malignant ascites.

DISEASE(S): Adenocarcinoma,Carcinoma,Colorectal Cancer,Breast Cancer,Peritoneal Carcinomatosis,Peritoneal Metastases,Peritoneal Neoplasms,Pancreas Cancer,Neoplasm Metastasis,Carcinoembryonic Antigen,Gastric Cancer,Ascites,Pancreatic Neoplasms

PROVIDER: 2285031 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2221147 | ecrin-mdr-crc
2019-02-12 | GSE126399 | GEO
| 2187897 | ecrin-mdr-crc
2024-10-17 | GSE279348 | GEO
| 2735463 | ecrin-mdr-crc
| 2336180 | ecrin-mdr-crc
2015-08-27 | E-GEOD-72398 | biostudies-arrayexpress
2021-08-24 | GSE182623 | GEO
| 2732525 | ecrin-mdr-crc
| 2182785 | ecrin-mdr-crc